Contact me at shengchenz@hanxinpharm.comI am looking for compounding pharmacy and ingredients wholesalers who have interests in compounded semaglutide/tirzepatide API. Our semaglutide is manufactured in FDA registered facility with the NDC code 83821-201-01; 83821-201-02; 83821-201-03; 83821-201-04Cutting edge biomanufacturing technology. amphastar.comhanxinpharm.com/en/As a business development manager at Hanxin Pharm, I leverage my expertise to drive sales and partnerships for our innovative products. Hanxin Pharm, originally the R&D center of Amphastar's facility in China, is a cutting-edge biomanufacturing company that manufacture API, intermediates, finished products, and provide CRO, CDMO, OEM service.Main products:1. Semaglutide(US NDC code granted): commercial production & appropriate specific activity & dissolution profile highly similar to reference product in vitro solubility. a) API tablet grade (98%/96% purity) b) API injection grade(99.5% purity) c) Intermediates: main chain(P29) and side chain d) API tablets: registered in Laos; semaglutide + SNAC granule (3mg/7mg/14mg) e) API injection pen finished product2. Liraglutide3. Tirzepatide4. Ganirelix Acetate5. Epinephrine Hydrochlaride6. Insulin Aspart7. Insulin Degludec8. Low molecule chondroitin sulfate: a) Verified pre-clinical study: 4x better bio-availability than normal chondroitin sulfate, 2.4% vs 0.6% b) GRAS certificate granted in US c) Low viskosity, great solubility & easy absorbption d) Patent protected: strain, composition, process, application patents all well-equipped9. Terbinafine HCL10. Megestrol Acetate

About us:Foregen, a global biotech corporation with well-built industry chain in R&D, manufacturing, logistics and marketing. Our mission is to support more lives through premium quality, sustainable ingredients for a healthier tomorrow.We have scientists in US providing their unique insights into metabolic pathway and R&D department in Shanghai for manufacturing technology breakthroughs. Our scaled facilities, one of which covers over 100,000 square meters, allow us to deliver the fastest solution and most competitive pricing to every partner. Over 30 patents related to L-ergothioneine, beta-alanine, L-BAIBA(L-β-aminoisobutyric acid), BHB salts(beta-hydroxybutyrate), grain of paradise etc. All those patent-protected technology ensure that we produce ingredients with better bioavailability and through purely Non-GMO pathway.We have made some vitro/animal pre-clinical studies and preliminary bioavailability studies to evaluate our products. Currently we are applying for the GRAS of our novel ingredient γ-glutamylcysteine(GGC) and designing clinical trials to validate it as a superior option than glutathione. We are always developing more ingredients and planning on more studies. Technology innovation and scientific validation are our main focus and also strength that make us satisfy all types of needs!Efficient logistic network, e.g. warehouses in CA and TX.Marketing subsidiary company based in Jiang Su.ODI subsidiary companies in Hong Kong and US.

Proficiency in sports & dietary nutrition, human metabolism & anatomy.Expert in customizing split system training plan and diet design based on client's stage.